# Genetic Testing Decision Aid

> **NCT05470920** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 350 (estimated)

## Conditions studied

- Epithelial Ovarian Carcinoma
- Pancreas Adenocarcinoma

## Interventions

- **BEHAVIORAL:** Electronic Decision Aid
- **BEHAVIORAL:** Pre-Test Genetic Counseling

## Key facts

- **NCT ID:** NCT05470920
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-14
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470920, "Genetic Testing Decision Aid". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05470920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*